INTRODUCTION {#S1}
============

The term RNAi originally refers to the phenomenon of exogenous dsRNA-triggered gene silencing ([@R13]; [@R23]; [@R25]), in which target mRNA is degraded by a small interfering RNA (siRNA)-associated Argonaute (AGO) protein, resulting in post-transcriptional gene silencing (PTGS) ([@R12]; [@R21], [@R22]; [@R45]). In addition to this mechanism, siRNAs can also target a gene for transcriptional gene silencing (TGS) in plants, fungi, and animals ([@R31]; [@R38]; [@R40]; [@R47]). We will use the terms classical RNAi and nuclear RNAi to refer to PTGS and TGS, respectively. Classical RNAi results in rapid degradation of exogenous dsRNA and homologous single-stranded transcripts, while long-term, stable silencing of transposons and other types of repetitive genomic elements is facilitated by nuclear RNAi.

In *C. elegans*, nuclear RNAi effects include histone modifications (H3K9me3 and H3K27me3) and transcriptional repression at endo-siRNA-targeted loci ([@R8]; [@R19]; [@R20]; [@R30]). The study of the endogenous silencing events, which provide a rich source of targets to study the physiological functions and underlying mechanisms, is further complemented by highly manipulatable approaches using exogenous triggers such as dsRNA or transgenes ([@R5]; [@R19]; [@R20]; [@R27]; [@R33]; [@R39]). Exogenous dsRNA-induced nuclear RNAi relies on the upstream steps of classical RNAi for siRNA biogenesis ([@R18]; [@R19]), but also requires nuclear RNAi-specific protein factors, including the germline-specific nuclear AGO protein WAGO-9/HRDE-1 ([@R1]; [@R5]; [@R8]; [@R20]; [@R39]; [@R42]; [@R48]). The germline nuclear RNAi pathway is essential for various transgenerational silencing phenomena in *C. elegans* ([@R2]; [@R5]; [@R6]; [@R9]; [@R19]; [@R27]; [@R33]; [@R39]). In the case of exogenous dsRNA-induced heritable RNAi, the heterochromatin response, as well as the silencing effect, can persist for multiple generations after the initial dsRNA exposure (administered by feeding or injection) has been ceased ([@R2]; [@R5]; [@R8]; [@R18]; [@R19]; [@R30]; [@R46]), providing a highly tractable system to study the transgenerational epigenetic inheritance of silencing.

The germline nuclear RNAi pathway plays an important role in maintaining genome stability ([@R6]; [@R32]; [@R34]) and is essential for germline development when *C. elegans* is under heat stress ([@R5]; [@R8]; [@R35]; [@R48]). Sequencing study of HRDE-1-associated endogenous siRNAs (endo-siRNAs) suggest that a diverse set of genomic regions can be targeted by the germline nuclear RNAi pathway ([@R8]). We previously refined the putative endogenous targets by identifying ones that lose H3K9me3, transcriptional repression, or both in mutant animals that lack HRDE-1 ([@R34]). We refer to these targets as the exemplary endogenous targets of germline nuclear RNAi, which primarily consist of long terminal repeat (LTR) retrotransposons, but also include other types of repetitive DNA and some protein-coding genes. Interestingly, regions with germline nuclear RNAi-dependent heterochromatin (GRH) and regions with germline nuclear RNAi-dependent transcription silencing (GRTS) only partially overlap, raising the question whether the nuclear RNAi-dependent transcriptional silencing can be caused by a heterochromatin-independent mechanism ([@R23]; [@R34]).

To investigate the function of heterochromatin in this pathway, we and others found that germline nuclear RNAi-dependent H3K9 methylation requires multiple putative histone methyl-transferases (HMTs), MET-2, SET-25, and SET-32 ([@R23]; [@R30]; [@R42]). All three proteins contain the SET domain, an evolutionarily conserved moiety that methylates the lysine residues of histone proteins. Based on the H3K9 methylation levels in the embryos of various mutant strains, MET-2 has been proposed to be a mono- and di-methylase for H3K9, and SET-25 a tri-methylase for H3K9 ([@R15]; [@R44]). Mutant adults that lack SET-32 also show significant loss in the H3K9me3 chromatin immunoprecipitation (ChIP) signal ([@R23]). None of the three proteins have been biochemically characterized for the HMT activity. Studies using different experimental setups and target genes have reported that these putative H3K9 HMTs are required for the siRNA-guided epigenetic silencing in some cases ([@R5]; [@R33]; [@R42]), but are dispensable in others ([@R23]; [@R28]; [@R33]). *met-2* mutant animals even exhibit the phenotype of enhanced heritable RNAi ([@R28]). We recently showed that H3K9me3 can be decoupled from transcriptional repression in nuclear RNAi ([@R23]). Abolishing the H3K9me3 deposition by mutating all three putative HMT genes (*met-2*, *set-25*, and *set-32*) did not lead to any de-repression at the endogenous HRDE-1 targets (the ones targeted by endo-siRNAs), nor did it cause any defects in transcriptional silencing or heritable silencing at a gene targeted by exogenous dsRNA. This argues against a simple model in which H3K9me3 plays a direct or dominant role in transcriptional repression at the nuclear RNAi targets. However, for the endogenous targets, our previous study only examined the requirement of these proteins in maintenance of silencing. It is unknown whether any of the MET-2, SET-25, and SET-32 is required for *de novo* silencing of actively transcribed endogenous targets. For studies using exogenous dsRNA-induced nuclear RNAi, worms were first exposed to dsRNA for several generations to achieve the steady-state level of repression before the silencing effects were examined ([@R23]). Therefore, the roles of putative H3K9 HMTs in the onset of nuclear RNAi were unknown.

In principle, a genome surveillance mechanism should consist of at least two distinct phases: establishment and maintenance of silencing. The establishment phase involves the recognition of foreign genetic material and the onset of silencing. Once initiated, the silencing state is then inherited or reinforced in the maintenance phase. In the case of exogenous dsRNA-induced nuclear RNAi, the establishment phase can be defined as the period in which dsRNA leads to the maximal level of transcriptional repression at the target gene, while the maintenance phase can be defined as the period in which a steady-state-level transcriptional repression has been reached in the presence of dsRNA. The maintenance phase is followed by the inheritance phase, in which the transcriptional repression persists, but eventually dissipates, in the progeny that are no longer exposed to dsRNA. Both the maintenance and inheritance phases of nuclear RNAi have been actively investigated. However, the establishment of the nuclear RNAi has not been carefully characterized. Previous studies observed a one-generation delay between the initial dsRNA treatment and the nuclear RNAi effects ([@R8]; [@R10]; [@R19]), suggesting that the establishment of nuclear RNAi is a transgenerational process. It is still unknown how soon the transcriptional repression can occur after the initial dsRNA exposure. Most of the published studies rely on phenotype or protein expression to measure the silencing state. As such, a lack of transcriptional repression can be masked by an active classical RNAi (post-transcriptional silencing).

In the case of the endogenous nuclear RNAi targets (guided by endo-siRNAs), the establishment phase likely occurs soon after the first invasion of an LTR retrotransposon or other types of repetitive DNA into the *C. elegans* genome. We and others previously found that the transcription of these endogenous targets are highly active in the *hrde-1* and other nuclear RNAi mutants ([@R8]; [@R34], [@R35]), indicating that these targets still contain their transcriptional activating cis-regulatory elements. It remains an open question how soon a transposable element is silenced after its initial integration into the genome. Transgene has a strong tendency to be silenced in the *C. elegans* germline ([@R24]). Interestingly, the silencing does not occur immediately after the transformation but gradually reaches the highest level over a course of multiple generations ([@R24]), suggesting that the establishment of silencing at a transgene is a transgenerational process. The establishment process at the endogenous nuclear RNAi targets is highly important to our knowledge of genome surveillance. However, this process is largely elusive due to a lack of experimental system. Published work on the endogenous targets have been limited on the maintenance phase. In this study, we developed different strategies to examine the establishment process of silencing for an exogenous dsRNA target and endogenous targets. In these experiments, both types of targets started with active transcription. We monitored the onset of repression for multiple generations, and, for the endogenous targets, at the whole-genome level. We found that the establishment of nuclear RNAi is a transgenerational process and requires SET-32 and SET-25, although at different degrees.

RESULTS {#S2}
=======

The Onset of Nuclear RNAi-Mediated Silencing in Wild- Type Animals Occurs One Generation after the Exogenous dsRNA Exposure {#S3}
---------------------------------------------------------------------------------------------------------------------------

To investigate the transgenerational onset of nuclear RNAi, we performed a five-generation *oma-1* RNAi experiment by feeding worms with *oma-1* dsRNA-expressing *E. coli* ([Figure 1A](#F1){ref-type="fig"}). *oma-1* is a non-essential germline-specific gene ([@R29]) and has been routinely used to study nuclear RNAi and epigenetic inheritance of silencing. In this experiment, young adult worms that were exposed to *oma-1* dsRNA for one to five generations were collected (referred to as F1\[dsRNA^+^\] to F5\[dsRNA^+^\] animals). Adult worms fed on *E. coli* OP50, which does not express any worm-specific dsRNA, were used as the control (dsRNA^−^ control).

To examine the nuclear RNAi-mediated silencing at *oma-1*, we measured the *oma-1* pre-mRNA levels by using RT-qPCR, with random hexamer oligoes as the RT primer and an *oma-1* intron-specific and an exon-specific primer for the qPCR. To examine the combined effects of classical RNAi and nuclear RNAi at *oma-1*, we measured the oma-1 mature mRNA levels using the oligo-dT as the RT primer and two exon-specific primers for the qPCR. The same strategy has been used in our previous study ([@R23]).

The wild-type animals exhibited robust repression of *oma-1* at the mRNA level in F1(dsRNA^+^), with approximately 78% reduction compared to the dsRNA^−^ control animals ([Figure 1B](#F1){ref-type="fig"}). Further reduction in *oma-1* mRNA was observed in the F2(dsRNA^+^) animals.

Compared to the repression measured at the *oma-1* mRNA level, the one at the pre-mRNA level was delayed by one generation in wild-type animals. The level of *oma-1* pre-mRNA was reduced by 23% or remained unchanged in F1(dsRNA^+^) animals compared to the dsRNA^−^ control (two biological replicates; Figures [2C](#F2){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). The levels of *oma-1* pre-mRNAs in F2--F5(dsRNA^+^) samples were relative stable, at approximately 40% of the one in the dsRNA^−^ control. This result suggests a difference in the speed of onset between classical RNAi and nuclear RNAi in wild-type animals: a robust silencing mediated by the classical RNAi begins within the first generation of dsRNA exposure, and a robust silencing mediated by the nuclear RNAi begins at the second generation.

We also examined the level of H3K9me3 at the *oma-1* locus in the same samples of the F1(dsRNA^+^) and F2(dsRNA^+^) wild-type animals by performing H3K9me3 chromatin immunoprecipitation sequencing (ChIP-seq) analysis. We found that both samples exhibited high levels of H3K9me3 in *oma-1* gene ([Figure 1D](#F1){ref-type="fig"}), and the levels were similar to our previously reported level in animals treated with *oma-1* dsRNA for three to four generations ([@R23]). Therefore, the onset of robust H3K9me3 at *oma-1* begins at the first generation of dsRNA exposure, one generation earlier than the transcriptional repression.

As a control for the requirement of nuclear RNAi for the observed transcriptional repression of *oma-1*, we examined the *oma-1* pre-mRNA and mRNA levels in *hrde-1* mutant animals fed with *oma-1* dsRNA. Similar to N2, *oma-1* expression at the pre-mRNA level was not repressed in the F1(dsRNA^+^) *hrde-1* animals ([Figure 1C](#F1){ref-type="fig"}), confirming the requirement of nuclear RNAi for the transcriptional repression. Interestingly, *oma-1* RNAi led to a progressive increase in *oma-1* pre-mRNA level in the F2--F5(dsRNA^+^) *hrde-1* animals. The same effect was observed in our previous study ([@R23]). Here, we also performed the *oma-1* RNAi experiment in *nrde-2* mutant strain for three generations, which is also defective in nuclear RNAi ([@R20]), and again observed progressively increased *oma-1* pre-mRNA levels compared to dsRNA^−^ control *nrde-2* mutant animals ([Figure S1A](#SD1){ref-type="supplementary-material"}). These results suggest that exogenous dsRNA can affect transcription or co-transcriptional RNA processing in a nuclear RNAi-independent manner. Future studies are required to investigate the nature of such effect.

Despite the increased pre-mRNA, we observed approximately 40% reduction in *oma-1* mRNA in both the F1(dsRNA^+^) and F2(dsRNA^+^) *hrde-1* animals compared to the dsRNA^−^ control *hrde-1* animals ([Figure 1B](#F1){ref-type="fig"}). The reduction is consistent with the previous finding that the classical RNAi is active in the *hrde-1* mutant ([@R8]; [@R23]). However, the *oma-1* mRNA levels in the F1(dsRNA^+^) and F2(dsRNA^+^) *hrde-1* animals were much higher than the F1(dsRNA^+^) and F2(dsRNA^+^) wild-type animals ([Figure 1B](#F1){ref-type="fig"}). This may due to the active transcription of *oma-1*, a partial defect of classical RNAi in the *hrde-1* mutant, or both. Further study is required to distinguish these possibilities.

*set-32* Mutation Results in a More Gradual, Multigenerational Establishment of exo-dsRNA-Induced Transcriptional Repression {#S4}
----------------------------------------------------------------------------------------------------------------------------

To investigate whether any of the putative H3K9 HMTs plays a role in the establishment of transcriptional repression, we performed multigenerational *oma-1* RNAi experiments using *set-32*, *met-2*, and *set-25* single-mutant strains, as well as the *met-2* *set-25* double mutant. Two different *set-32* mutant alleles were used in this study. One is the *set-32(ok1457)* allele ([@R11]) which has an in-frame deletion of 156 aa (position 50--205), located before the SET domain, and has been used in previous studies ([@R5]; [@R23]). In this study, we also used clustered regularly interspaced short palindromic repeats (CRISPR) to generate a second allele, *set-32(red11)*, which lacks the SET domain. We measured the dsRNA-induced H3K9me3 at *oma-1* using this new allele (three to four generations of dsRNA^+^), and found that, same as *set-32(ok1457)*, *set-32(red11)* caused a significant reduction in, but did not completely abolish, the RNAi-induced H3K9me3 ([Figure S2C](#SD1){ref-type="supplementary-material"}). Also, the same as previously observed for the *set-32(ok1475)* mutant ([@R23]), *set-32(red11)* mutant animals exhibited no defect in heritable RNAi after three to four generations of exo-dsRNA exposure ([Figures S2A and S2B](#SD1){ref-type="supplementary-material"}). For the onset of silencing, *oma-1* mRNA was robustly silenced by RNAi in both *set-32* mutant alleles at the first generation of the dsRNA exposure, similar to wild-type animals ([Figure 1B](#F1){ref-type="fig"}). Interestingly, the onset of nuclear RNAi, measured by pre-mRNA, was much slower in *set-32* mutant than the wild-type animals. Both *set-32* mutant alleles generally had higher *oma-1* pre-mRNA than wild-type animals in the first four dsRNA^+^ generations (Figures [1C](#F1){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). It was at the fifth generation when the repression reached the steady-state level observed in the wild-type animals (Figures [1C](#F1){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). Therefore, *set-32* mutation causes a multigenerational delay in dsRNA-triggered transcriptional repression. We also tested *met-2*, *set-25*, and *met-2* *set-25* mutant animals. All three mutants exhibited wild-type-like profiles in pre-mRNA repression at the first and second generations of the dsRNA exposure ([Figure S1B](#SD1){ref-type="supplementary-material"}). These results suggest that, although both SET-32 and MET-2 SET-25 contribute to the H3K9me3 at the RNAi target, their functions are not equivalent. SET-32-dependent activity, but not MET-2 SET-25-dependent activity, promotes the onset of exogenous dsRNA-induced transcriptional repression. The SET domain of SET-26 can methylate H3K9 *in vitro* ([@R17]). We previously showed that neither SET-26 nor SET-9, which is 96% identical to SET-26 at the amino acid level, is required for the dsRNA-induced H3K9me3 at *oma-1* ([@R23]). Here, we found that the *set-9 set-26* double mutant had no defect in the onset of the dsRNA-induced transcriptional repression at *oma-1* ([Figures S1C and S1D](#SD1){ref-type="supplementary-material"}).

To examine inheritance of silencing induced by a shorter duration of dsRNA exposure (one or two generations as opposed to four), we cultured the progeny of dsRNA-exposed animals on OP50 plates that lacked *oma-1* dsRNA for one or two generations (referred to as inheritance generations) ([Figure 1A](#F1){ref-type="fig"}). For wild-type animals, both one-generation and two-generation dsRNA exposures resulted in robust repression at the pre-mRNA level in the inheritance generations ([Figures 1E and 1F](#F1){ref-type="fig"}). Interestingly, after only one generation of dsRNA exposure, the first and second inheritance generations showed progressively stronger *oma-1* repression at the pre-mRNA levels ([Figure 1E](#F1){ref-type="fig"}), suggesting that the transgenerational establishment of transcriptional repression does not require continuous dsRNA exposure. For *set-32* mutants, we again observed delayed nuclear RNAi in the inheritance generations ([Figures 1E and 1F](#F1){ref-type="fig"}), confirming the role of SET-32 in promoting the establishment of nuclear RNAi-mediated silencing.

Developing a CRISPR-Based Approach to Study the Establishment of Silencing at the Endogenous Targets of Germline Nuclear RNAi {#S5}
-----------------------------------------------------------------------------------------------------------------------------

One challenge of studying the establishment of silencing at the endogenous targets (ones targeted by endo-siRNAs) is to begin with an actively transcribed target for the experiment. This can be achieved at the whole-genome level by using a nuclear RNAi-defective mutant, such as *hrde-1*, in which a defined set of endogenous targets are actively transcribed ([@R8]; [@R34], [@R35]). To examine the establishment of silencing at these endogenous targets, we used CRISPR-mediated gene conversion to repair the loss-of-function *hrde-1*(*tm1200*) mutation in worms that had carried the *hrde-1* mutation for more than 20 generations. We wanted to know how fast the repressive states can be established at the endogenous nuclear RNAi targets when the HRDE-1 activity is restored. Besides the CRISPR method, a wild-type *hrde-1* allele can also be introduced to the *hrde-1* mutant strain via a genetic cross. We did not choose this method because genetic crosses will introduce epigenetically repressed alleles of the endogenous targets, as well as a foreign siRNA population.

To repair the *hrde-1* mutation using CRISPR, a mixture of *hrde-1*-targeting Cas9 ribonuclease complex and repair template DNA was injected into the gonads of *hrde-1* mutant hermaphrodite adults ([Figure 2A](#F2){ref-type="fig"}). The wild-type *hrde-1* allele generated by gene conversion was annotated as *hrde-1*(+^R^), and the naive wild-type *hrde-1* allele (i.e., an allele that never experienced any mutation) as *hrde-1* (+). Progeny of the injected animals were produced by self-fertilization throughout the experiment. The F1 *hrde-1*(+^R^/−) and F2 *hrde-1*(+^R^/+^R^) individuals were identified by PCR and Sanger sequencing. We then collected later generations of the homozygous *hrde-1* (+^R^) adults and examined the abundance of the transcripts of the endogenous targets. The F3 was the earliest generation that can be collected for the assay because the F1 and F2 progeny were used for genotyping. We measured the abundance of the transcripts for two endogenous targets by RT-qPCR. Both established their repressive states in the F3 *hrde-1*(+^R^) and later generations (two biological replicates; [Figures 2B and 2C](#F2){ref-type="fig"}). We also identified the F2 *hrde-1*(−/−) individuals and collected their progeny (F3) and performed RT-qPCR analysis ([Figure S3D](#SD1){ref-type="supplementary-material"}). The endogenous targets remained de-repressed in the F3 *hrde-1*(−/−) progeny ([Figure S3D](#SD1){ref-type="supplementary-material"}), as expected. These results indicate that silencing of endogenous targets can be established at the F3 generation after repairing the *hrde-1* mutation by gene conversion.

SET-32 Is Required for the Establishment of Silencing for Some of the Endogenous Targets {#S6}
----------------------------------------------------------------------------------------

To test whether the putative H3K9 HMTs are required for establishment of silencing at the endogenous targets, we generated *set-32;hrde-1* and *met-2 set-25 hrde-1* mutant strains. Two different alleles (*ok1457* and *red11*) of *set-32* mutations were used this experiment. For *set-32(ok1457)*, we collected F3, F5, F8, and F20 populations after the gene conversion. For *set-32(red11)*, we collected F3, F4, F5, and F20 populations. Both *set-32* alleles exhibited a delay in the establishment of silencing for eight or five generations. Full repressions of these targets were reached at the F20 generation ([Figures 2B and 2C](#F2){ref-type="fig"}). We confirmed that the early generations of the *hrde-1*(+^*R*^) animals had similar *hrde-1* mRNA expressions as the *hrde-1* (+) animals ([Figure S3](#SD1){ref-type="supplementary-material"}). Therefore, the delayed establishment of silencing is not due to a lower *hrde-1* mRNA expression in the early post-conversion generations. For the *met-2 set-25 hrde-1* mutant strain, two independent lines of *met-2 set-25 hrde-1* \[+^R^/+^R^\] worms were followed and both fully established the repressive states by the F3 generation for the two tested targets ([Figure 2B](#F2){ref-type="fig"}).

To examine the establishment of silencing at the whole-genome level, we performed RNA sequencing (RNA-seq) for the post-conversion populations (*hrde-1* \[+^R^/+^R^\], *set-32;hrde-1* \[+^R^/+^R^\], and *met-2 set-25 hrde-1* \[+^R^ /+^R^\]), as well as animals of the identical genotypes but with the naive wild-type *hrde-1* allele (*hrde-1*\[+/+\], *set-32;hrde-1* \[+/+\], and *met-2 set-25 hrde-1*\[+/+\]). We sequenced rRNA-depleted total RNA of each sample in order to include both polyadenylated RNA and non-polyadenylated RNA. For the post-conversion samples, we performed RNA-seq for the F4, F5, and F20 populations for *hrde-1*(+^R^), F3, F5, and F20 for *met-2 set-25 hrde-1*(+^R^), F5, F8, and F20 for *set-32(ok1457)* *hrde-1*(+^R^), and F4, F5, and F20 for *set-32(red11)* *hrde-1*(+^R^). Our whole-genome analysis indicated that repairing *hrde-1* mutation fully silenced all of the endogenous targets as early as in the F4 post-conversion population of the animals carrying the wild type *met-2*, *set-25*, and *set-32* genes ([Figures 3A and 3E](#F3){ref-type="fig"}). In contrast, some of the endogenous targets remained actively expressed even in the F20 post-conversion populations of animals carrying either the *set-32(red11)* or *set-32(ok1457)* mutation ([Figures 3C--3E](#F3){ref-type="fig"}). These targets are referred to as putative irreversible targets. After examining the RNA-seq profiles individually, we identified four exemplary irreversible targets, which include two LTR retrotransposons (Cer9 and Cer12), a putative protein-coding gene c38d9.2 in chromosome V, and an approximately 5-kb region in chromosome II (containing two uncharacterized putative protein-coding genes *f15d4.5* and *f15d4.6*) (Figures [3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}--[S8](#SD1){ref-type="supplementary-material"}). All of these loci became transcriptional activated in *hrde-1* and *set-32;hrde-1* mutants, but remained silent in *set-32* mutant (with naive wild-type *hrde-1*), despite the losses of H3K9me3 at these regions (Figures [3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}--[S8](#SD1){ref-type="supplementary-material"}). These data confirm our previous finding that SET-32 is dispensable for the maintenance of silencing at the native HRDE-1 targets ([@R23]). These irreversible targets represent a bona fide epigenetic phenomenon in which two genetically identical populations (cultured in the same conditions and harvested at the same developmental stage) exhibit different gene expression profiles.

We found that *met-2 set-25* are required for the establishment of silencing in only one of the four irreversible targets, *c38d9.2* ([Figure S7](#SD1){ref-type="supplementary-material"}). Our global analysis indicated that most of the endogenous targets established the silencing states as early as in the F3 *met-2 set-25 hrde-1*(+^R^) populations ([Figures 3B and 3E](#F3){ref-type="fig"}).

We also performed the silencing establishment assay using the *set-32;met-2 set-25 hrde-1* mutant strain. All four irreversible targets identified in the *set-32* mutant ground failed to initiate the silencing the F5 *set-32;met-2 set-25 hrde-1*(+^R^) population (Figures [S4](#SD1){ref-type="supplementary-material"}--[S8](#SD1){ref-type="supplementary-material"}). The expression levels of these targets in F5 *set-32;met-2 set-25 hrde-1*(+^R^) and F5 *set-32; hrde-1*(+^R^) were similar.

We note that majority of the irreversible targets in *set-32* mutant belong to the GRTS regions. In contrast, most of the GRH regions restored the transcriptional repression by the F4--F5 post-repair generation in the *set-32* mutant background ([Figures 3C--3E](#F3){ref-type="fig"}). Taken together, our results indicate that SET-32 is required for the establishment of the repression states of some endogenous HRDE-1 targets. Although *met-2 set-25* mutant animals had a much weaker phenotype than *set-32* in this assay, we cannot rule out that MET-2 and SET-25 are required for the establishment of silencing in the first and second post-conversion generations, which were precluded in the assay due to the screening procedure after CRISPR.

To explore the role of endo-siRNAs in the establishment of silencing, we performed small RNA-sequencing (sRNA-seq) analysis for the pre-conversion samples, the F5 and F20 post-conversion generations, and the matching samples with the naive wild-type *hrde-1* allele. We found that the endo-siRNA profiles at the irreversible targets in *set-32 hrde-1* (+) was similar to the ones in the wild-type (WT) animals, arguing against an active role of SET-32 in promoting the endo-siRNA levels at these targets. The *set-32 hrde-1* (−) and the post-conversion *set-32 hrde-1* (+^R^) animals had abundant endo-siRNAs at the irreversible targets. Their profiles were different from the ones in the *set-32 hrde-1*(+) but similar to the ones in the *hrde-1*(−) animals (Figures [S5](#SD1){ref-type="supplementary-material"}--[S8](#SD1){ref-type="supplementary-material"}). These results argue against the possibility that the delayed establishment of silencing observed in *set-32* mutant is caused by a lag in endo-siRNA expression. The changes in the endo-siRNA expressions in the *set-32 hrde-1*(−) and the post-conversion *set-32 hrde-1* (+^R^) animals, in comparison to WT animals, are likely due to the increased transcripts of the irreversible targets, which template the endo-siRNA synthesis.

H3K9 HMTs Are Required to Maintain the Repressive States for Some Endogenous HRDE-1 Targets in *hrde-1* Mutant Animals {#S7}
----------------------------------------------------------------------------------------------------------------------

We performed Pol II ChIP-seq and RNA-seq analyses for various compound mutants including *set-32;hrde-1*, *met-2 set-25 hrde-1*, and *set-32;met-2 set-25 hrde-1*. As expected, the endogenous HRDE-1 targets were de-repressed in these compound mutants ([Figures S9A and S9B](#SD1){ref-type="supplementary-material"}). Intriguingly, for a small subset of the targets, the *hmt; hrde-1* compound mutants exhibited much higher RNA expression and Pol II occupancy than the *hrde-1* single mutant (Figures [4A](#F4){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}), indicating that the loss of H3K9me3 further enhances the *hrde-1* mutation's defects in transcriptional repression for these targets. Such enhancement is unexpected because *set-32*, *met-2 set-25*, *set-32;met-2 set-25* mutant animals have no silencing defects at the endogenous targets, as reported previously ([@R23]) and shown again using the new data generated in this study ([Figure S9](#SD1){ref-type="supplementary-material"}). An exemplary endogenous target with such enhanced de-repression is the LTR retrotransposon Cer3 ([Figures 4B--4D](#F4){ref-type="fig"}). Either *set-32* single or *met-2 set-25* double mutations, when combined with the *hrde-1* mutation, drastically increased the Pol II occupancy at Cer3 and Cer3 transcripts. Therefore, the enhanced de-repression occurs at the transcriptional level. The enhanced de-repression caused by different H3K9 HMTs appears to be additive because the quadruple mutant of *set-32;met-2 set-25 hrde-1* showed the highest Cer3 expression ([Figures 4C and 4D](#F4){ref-type="fig"}). Interestingly, Cer3 is not an irreversible target ([Figure 4E](#F4){ref-type="fig"}). These results indicate that, for a small subset of the endogenous targets, H3K9me3 HMTs are required for the maintenance of repression. However, such requirements are only apparent when HRDE-1 activity is compromised. We note that, for the majority of the endogenous HRDE-1 targets, the combined mutations in H3K9 HMT genes and *hrde-1* had no additive effect of de-repression compared to the *hrde-1* single mutant ([Figure S9](#SD1){ref-type="supplementary-material"}).

DISCUSSION {#S8}
==========

The Establishment and Maintenance Phases of Germline Nuclear RNAi in *C. elegans* {#S9}
---------------------------------------------------------------------------------

H3K9me3 is an evolutionarily conserved nuclear RNAi effect in fungi, plants, and animals. In *C. elegans*, this effect is highly specific and prominent at target loci. Furthermore, it is transgenerationally heritable and linked to the germline immortality ([@R5]; [@R8]; [@R10]; [@R19]; [@R39]; [@R48]). H3K9me3 at nuclear RNAi targets requires three putative HMTs: MET-2, SET-25, and SET-32 ([@R23]; [@R30]; [@R42]). Strikingly, we previously found that a complete loss of H3K9me3 in the mutant worms that lack the three HMTs did not cause any defect in transcriptional repression at the endogenous targets ([@R23]). The experimental setup in the previous study was designed to examine the maintenance of silencing and precluded us from studying the establishment phase. For a newly inserted transposon that is transcriptionally active, the establishment phase precedes the maintenance phase and two phases may involve different mechanisms.

Exo-dsRNA-triggered nuclear RNAi provides an inducible system in which to study the establishment, maintenance, and inheritance of epigenetic silencing at a gene that is normally actively expressed. The previous discovery of a transgenerational delay in the onset of H3K9me3 at the target gene ([@R10]; [@R19]) suggests that the establishment of nuclear RNAi is a gradual process. The kinetics of transcriptional repression during the early generations of dsRNA exposure have not been examined before this study.

In this study, we examined the establishment phase for both endo-siRNA-guided and exogenous dsRNA-triggered nuclear RNAi. Based on the results of this and our previous work ([@R23]), we propose a model in which the establishment and maintenance phases of nuclear RNAi have the following distinctions ([Figure 5](#F5){ref-type="fig"}).

1.  The transcriptional state of the target locus. At the maintenance phase, the target is stably repressed and kept in a heterochromatic state. In contrast, the establishment phase begins with an actively transcribed and euchromatic state at the target locus. Converting from an active state to a stably repressed state requires removal of euchromatic marks and the deposition of heterochromatic marks. Therefore, the speed of the silencing establishment may depend on the relative strengths of the two opposing forces.

2.  Silencing mechanism. We propose that nuclear RNAi consists of multiple distinct silencing mechanisms. One of these mechanisms is an H3K9me3-independent silencing mechanism, which likely is the main source of silencing during the maintenance phase. The active transcription during the establishment phase may pose a strong force against the H3K9me3-independent silencing mechanism. Such antagonistic interactions between euchromatin (H3K36me3) and heterochromatin have been shown to occur in the *C. elegans* germline ([@R16]; [@R48]). It is conceivable that SET-32-depedent H3K9me3 promotes the onset of silencing, either by providing an additional force of repression (H3K9me3-dependent in this case) or by enhancing the efficacy of H3K9me3-independent silencing mechanism. However, given enough time, H3K9me3-independent mechanisms can eventually establish silencing in the absence of SET-32. Although the prolonged lag in silencing is tolerated by the mutant worms at the organismal level in the laboratory condition, this molecular defect may create a window for the transposition of a newly invaded mobile DNA, and therefore it is likely to be selected against in a wild population.

The establishment phase of an epigenetic silencing phenomenon is often difficult to study because of its transient nature. The *set-32* mutation slows down the onset of silencing and therefore provides an expanded window to dissect the extraordinarily complex process.

Although MET-2, SET-25, and SET-32 all contribute to the H3K9me3 at the nuclear RNAi targets, SET-32 and MET-2 SET-25 are not equivalent in their role in silencing establishment. This may due to differential expression of these proteins. Alternatively, the functional difference could be due to certain unknown H3K9me3-independent activities associated with individual enzymes. Future study is required to investigate these possibilities. In agreement with our finding, the study by [@R49] (in this issue of *Cell Reports*) found that SET-32 is required for the establishment of transge-nerational silencing induced by dsRNA at a gfp reporter gene. The Ashe group found that SET-25 is also required in the establishment. We found that SET-25 is required for the silencing establishment for one of the endogenous targets, but not the other SET-32-dependent ones, including the exogenous dsRNA-targeted *oma-1*. This difference is perhaps due to different chromatin structures and transcription activities at the target genes.

What Is the Functional Significance of the One-Generation Delay in Exo-dsRNA-Induced Nuclear RNAi? {#S10}
--------------------------------------------------------------------------------------------------

Although exo-dsRNA was used as an artificial means to induce RNAi in this study, it is akin to a situation in which host animals encounter viral nucleic acids. We speculate that such a delay is a consequence of the specialization of classical RNAi and nuclear RNAi: the former eliminates the immediate threat by degrading the target RNA, and the latter provides long-term silencing at the chromatin level, which is critical for the control of retroviruses or retrotransposons. One possible benefit of the delay of nuclear RNAi is to allow the biogenesis of secondary siRNAs ([@R37]; [@R41]), which requires mRNA as template for the RdRP activity. If both nuclear RNAi and classical RNAi are fully active at the initial encounter of dsRNA, germ cells may not be able to produce sufficient siRNAs to facilitate silencing inheritance.

CRISPR Provides a Unique Advantage for Studying Transgenerational Epigenetics {#S11}
-----------------------------------------------------------------------------

In this study, we used CRISPR-mediated gene editing to repair a mutation in the *hrde-1* gene, which allowed us to capture the graduate changes in the endogenous targets after the nuclear RNAi machinery is turned on in the subsequent generations. This approach is analogous to heat or small molecule-inducible gene expression, but without the need to change the native promoter or protein sequence of the inducible gene. This approach also avoids crossing two strains carrying different genetic and epigenetic backgrounds, which makes this approach highly tractable. (For example, there is no need to distinguish different epialleles.)

Our study showed that, after repairing *hrde-1*, WT animals fully restored silencing at the endogenous targets in the third generation. Our current implementation of CRISPR does not allow us to examine the first and second generations after the HRDE-1 activity is restored. The one-generation delay observed for the exo-dsRNA-triggered nuclear RNAi raises a possibility that the establishment of silencing at the endogenous targets may also have a transgenerational delay even in a WT H3K9 HMT background.

CRISPR-mediated genome editing provides a powerful tool for biomedical research and curing genetic diseases. Our study provides a cautionary example that repairing a mutated gene may not immediately restore the normal function expected for the WT allele. Therefore, epigenetic effects must be considered when editing genes, especially when chromatin factors and epigenetic pathways are involved.

STAR★METHODS {#S12}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S13}
----------------------------------------

Requests and further information for reagents and resources should be directed to and will be fulfilled by the Lead Contact, Sam G. Gu (<sam.gu@rutegers.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S14}
--------------------------------------

All *C.elegans* strains used in this study are listed in Key Resources Table. *C. elegans* was cultured with OP50 *E. coli* as the food source for all non-RNAi experiments ([@R7]). Worms were cultured at 20°C for all of the experiments conducted in this study. Synchronized young adult animals were ground in liquid nitrogen by mortar and pestle and stored at −80°C and used for all data analysis. Experiments involving WT and mutant *C. elegans* are approved by Rutgers Environmental Health and Safety under "recombinant DNA" protocol.

METHOD DETAILS {#S15}
--------------

### oma-1 RNAi experiments {#S16}

*oma-1* RNAi experiments were performed as described previously ([@R23]; [@R43]) with the following modifications. Two schemes of *oma-1* RNAi were used in this study. To examine the onset of RNAi, synchronized L1 larvae were released onto *oma-1* RNAi plates which contained *oma-1*-dsRNA-expressing *E. coli*. The young adult animals are referred to as F1(dsRNA^+^). To obtain worms of F2(dsRNA^+^) or with extended generations of dsRNA exposure, eggs from dsRNA^+^ adult animals were collected and hatched in M9 buffer. L1s were released onto *oma-1* RNAi plates for another generation of dsRNA exposure. Young adult animals (59-60 hours after L1 release at 20°C, before egg laying starts, but embryos are visible inside the uterus) were harvested for various assays throughout the experiments. For the *oma-1* heritable RNAi and H3K9me3 ChIP experiments in [Figure S2](#SD1){ref-type="supplementary-material"}, worms of mixed developmental stages were first cultured on *oma-1* RNAi plates continuously for 9-10 days starting with approximately 5 L3-L4 worms, followed by one round of synchronized culture on *oma-1* RNAi plates to collect young adults. Samples used in the same figure panel were prepared in parallel.

### Gene conversion to repair hrde-1 mutation using CRISPR-Cas9 {#S17}

We repaired the *hrde-1(tm1200)* mutation to the WT sequence by injecting a plasmid Cas9 plasmid and hrde-1-targeting a *hrde-1* targeting Cas-9 ribonuclease complex and PCR fragment as the repair template. A *dpy-10(cn64)* co-conversion marker was used ([@R4]; [@R36]). 10-15 adult hermaphrodite animals (P0s) of each strain were injected. We screened 48-96 F1s animals using single-worm PCR from broods of injected animals with high frequencies of roller F1s. This yielded with 2-8 F1s bearing potential gene conversion events (heterozygotes) identified by the size of PCR products. For each putative F1 hit, 12-24 F2 worms a WT copy of *dpy-10* were individually transferred to plates. After laying eggs, the F2 worms with homozygous WT *hrde-1* sequences were identified by PCR and Sanger sequencing. We refer to the CRISPR/Cas-9-generated WT *hrde-1* sequence as *hrde-1*(+^*R*^) to distinguish it from the naive WT *hrde-1* sequence, referred to as *hrde-1*(+). F3, F4, F5, F10, and F20 post-conversion adults were collected either by hand picking (F3 and F4) or synchronized culture (F5 and later generations). The control *hrde-1*(+) samples (WT, *set-32*, *met-2 set-25*, *set-32;* *met-2 set-25*) and *hrde-1*(−) samples (*hrde-1*, *set-32;* *hrde-1*, *met-2 set-25 hrde-1* and *set-32;* *met-2 set-25 hrde-1*) were collected by picking adult animals, identically to the F3 and F4 samples of the *hrde-1*(+^*R*^) samples.

### Total RNA extraction {#S18}

For samples of pooled whole worms, TRIzol reagent (Life Technologies) was added to the frozen sample of approximately 20 worms in the M9 buffer. To ensure break down of worm bodies, we used 3-4 cycles of freeze-thawing in TRIzol, then performed total RNA extraction according to the manufacture's protocol. This procedure yielded 1-3 μg of total RNA for each sample.

### mRNA and pre-mRNA RT-qPCR {#S19}

Total RNA extraction was performed using the TRIzol Reagent. 1 μg of total RNA was used for the first strand cDNA synthesis with Superscript III RT kit (Life Technologies) and oligo-dT as the primer for mRNA RT-qPCR and the random hexamers as the primer mix for pre-mRNA RT-qPCR.

qPCR was performed using KAPA SYBR FAST Universal 2 × PCR Master Mix (KAPA Biosystems) on a Mastercycler EP Realplex realtime PCR system (Eppendorf) according to the manufacturer's instructions. qPCR primers are listed in Key Resources Table. Each sample was processed in triplicate. Reported values for the fold change of mRNA and pre-mRNA were calculated using ΔΔCT analysis. *tba-1* was used as a reference gene.

### High-throughput sequencing {#S20}

Chromatin immunoprecipitation (ChIP): Pol II and H3K9me3 ChIP-seq was performed as described previously ([@R34]). The anti-RNA Pol II S2 antibody (ab5095, Abcam) and anti-H3K9me3 antibody (ab8898, Abcam) were used.

RNA-seq: Ribosomal RNA (rRNA) was removed from the total RNA using RNase H and anti-rRNA oligo mixture (total of 110, listed in [Table S1](#SD1){ref-type="supplementary-material"}). The rRNA-removal procedure was adopted from ([@R14]). Briefly 1.25 μg of anti-rRNA oligos were mixed with 0.5 μg total RNA in 1x Hybridization Buffer (100 mM Tris-HCl pH 7.4, 200mM NaCl) in a final volume of 8 μl. The sample was denatured at 95°C for 2 minutes, and then cooled at −0.1°C /sec to 45°C. Equal volumes of Hybridase Thermostable RNase H (5U/μl,Epicenter) and 10x RNaseH Reaction Buffer (500 mM Tris-HCl pH 7.4, 1 M NaCl, 200 mM MgCl~2~) were mixed and preheated to 45°C before use. 2 μl of the enzyme mix was added to each reaction mix, which was then incubated at 45°C for 1 hr. To remove DNA oligos, 5 μl TURBO DNase buffer, 3 μl TURBO DNase (Invitrogen), and 32 μl diH2O were added to the reaction mix, followed by 37°C incubation for 30 minutes. To purify RNA, 300 μl STOP solution (1 M ammonium acetate, 10 mM EDTA) was added to the reaction mix, followed by phenol/chloroform (1:1) extraction and ethanol precipitation. The resulting RNA (without poly(A) selection) was used to prepare the RNA-seq library as described previously ([@R34]).

siRNA-seq: small RNA isolation and RNA-seq library construction were performed as described previously ([@R34]).

All libraries were sequenced using Illumina HiSeq 2500 platform, with a 50-nt single-end run and dedicated index sequencing. All libraries used in this study are listed in [Table S2](#SD1){ref-type="supplementary-material"}.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S21}
---------------------------------------

Whole genome alignment of the sequencing reads to the *C. elegans* genome (WS190 version) was done using Bowtie (0.12.7) ([@R26]). Only perfectly aligned reads were used for data analysis. Reads that aligned to N different loci were scaled by a factor of 1/N. Custom R and python scripts were used in this study. Normalization based on total reads aligned to the whole genome for each library was used for all data analysis, except for the ΔPol II boxplot analysis in [Figure S9C](#SD1){ref-type="supplementary-material"}, where total reads count of the top 5th percentile of the Pol II signal in corresponding library was used as the normalization factor. The three-region Venn diagram was generated using a web-based software (<http://www.benfrederickson.com/venn-diagrams-with-d3.js/>). Wilcoxon signed-rank test was performed to calculate the p values for all box-plot analysis in Figures [3E](#F3){ref-type="fig"}, [S9C](#SD1){ref-type="supplementary-material"}, and [S9D](#SD1){ref-type="supplementary-material"}. Welch Two Sample t test was used to calculate all other p values.

DATA AND SOFTWARE AVAILABILITY {#S22}
------------------------------

The accession number for the raw sequencing data in the fastq format reported in this paper is NCBI GEO: GSE117662.
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![Multigenerational Analysis of Exogenous dsRNA-Triggered RNAi at *oma-1*\
(A) A schematic of the experiment. F1--F5(dsRNA^+^), adult animals fed on *oma-1* dsRNA-expressing *E. coli* for one to five generations, were used to test the establishment of silencing. F1' and F2'(dsRNA^−^), the first and second generation after shifting from *oma-1* dsRNA^+^ to dsRNA^−^, were used to test the inheritance of silencing.\
(B) *oma-1* mRNA RT-qPCR analysis of the control (dsRNA^−^), F1(dsRNA^+^), and F2(dsRNA^+^) samples.\
(C) *oma-1* pre-mRNA RT-qPCR analysis of the control (dsRNA^−^) and F1--F5(dsRNA^+^) samples. This is one of two biological replicates for this experiment. The second one is shown in [Figure S1](#SD1){ref-type="supplementary-material"}.\
(D) H3K9me3 ChIP-seq coverage plots for the *oma-1* locus (top panel) and LTR retrotransposon Cer3 (bottom panel). Wild-type animals of control (dsRNA^−^), F1(dsRNA^+^), and F2(dsRNA^+^) were used. Cer3, used as a control locus here, is an endogenous HRDE-1 target with a high level of H3K9me3, which is not affected by *oma-1* RNAi. All profiles are normalized by total reads aligned to the whole genome.\
(E) *oma-1* pre-mRNA RT-qPCR analysis of the progeny (F1'\[dsRNA^−^\] and F2'\[dsRNA^−^\]) of the F1(dsRNA^+^) animals.\
(F) *oma-1* pre-mRNA RT-qPCR analysis of the progeny (F1'\[dsRNA^−^\]) of the F2(dsRNA^+^) animals. The values for the control, F1(dsRNA^+^), and F2(dsRNA^+^) samples from (C) are also used in (E) and (F) for comparison. Each RT-qPCR result in (B), (C), (E), and (F) represent the mean value of n = 3; whiskers represent the SD.](nihms-1515794-f0002){#F1}

![Silencing Establishment Assay of Endogenous HRDE-1 Targets\
(A) A schematic of the silencing establishment assay using CRISPR-Cas9-mediated gene conversion of the *hrde-1(tm1200)* mutation to the wild-type sequence.\
(B and C) RT-qPCR analysis for two endogenous HRDE-1 targets at pre- and post-conversion generations, as well as samples with the identical genotypes as the post-conversion generations but without experiencing the *hrde-1* mutation (naive samples). RNA expressions in different samples were normalized to the ones in the wild-type strain (N2). Two biological replicates were shown in (B) and (C). Each RT-qPCR value in (B) and (C) represents the mean value of n = 3; whiskers represent the SD. The GRH locus used in this analysis is chrV:5471001--5479000. The GRTS locus used in this analysis is LTR retrotransposon Cer8, located at chrV:5179680--5191222. (GRH, germline nuclear RNAi-mediated heterochromatin; GRTS, germline nuclear RNAi-mediated transcriptional silencing. GRH and GRTS regions, as well as the annotated genes located in these regions, were from Tables S1--S3 of [@R34]).](nihms-1515794-f0003){#F2}

![RNA-Seq Analysis of Silencing Establishment at Endogenous HRDE-1 Targets\
(A--D) Scatterplot analysis of normalized RNA-seq counts for all 1-kb genomic regions comparing animals in the post-conversion generations with animals of the same genotype but without experiencing *hrde-1* mutation (naive samples). (A) Wild-type *set-32;met-2 set-25* background, (B) *met-2 set-25* double-mutant background, (C) *set-32(ok1457)* background, and (D) *set-32(red11)* background. GRTS and GRH regions (see [Figure 1](#F1){ref-type="fig"} legend for their definitions) are colored in red and blue, respectively.\
(E) Boxplot analysis of the changes in RNA expression of GRTS or GRH regions between post-conversion animals and the corresponding naive samples.\
(F) An exemplary endogenous HRDE-1 target (LTR retrotransposon Cer9) that is defective in silencing establishment in the *set-32* mutant for at least 20 generations, but not in the *met-2 set-25* mutant. Normalized total RNA-seq signals were plotted. Columns from left to right are the naive samples (*hrde-1\[+\]*), pre-conversion samples (*hrde-1\[−\]*), and F5 and F20 post-conversion samples (*hrde-1\[+^R^\]*). Different genetic backgrounds (wild-type \[WT\] or various H3K9 HMT mutants) are in different rows as indicated. All results represented here are normalized by total reads aligned to the whole genome.\*p\<7 ×10^−5^ (Wilcoxon singed-rank test).](nihms-1515794-f0004){#F3}

![Enhanced Silencing Defects in the Endogenous HRDE-1 Targets Caused by the Combination of H3K9 HMT and *hrde-1* Mutations\
(A) Scatterplots with changes in RNA-seq signals between a compound mutant and *hrde-1* single mutant plotted in the x axis and changes in Pol II ChIP-seq signals plotted in the y axis for all 1-kb genomic regions. Regions with ≥ 2-fold increases in both RNA expression and Pol II occupancy in all three *H3K9* *hmt;hrde-1* compound mutants over *hrde-1* single mutant were marked with red dots.\
(B--D) The H3K9me3 ChIP-seq (data from [@R23]) (B), Pol II ChIP-seq (S2 phosphorylated) (C), and RNA-seq (D) coverage plots at the LTR retrotransposon Cer3 in WT and various mutant animals. Panels marked with an asterisk (\*) use a different scale to accommodate the enhanced expression levels observed for the genotype.\
(E) RNA-seq profiles at Cer3 for post-conversion samples (*hrde-1*\[+^R^/+^R^\]) with WT H3K9 HMT genes or various H3K9 HMT mutations. All results represented in this figure are normalized by total reads aligned to the whole genome.](nihms-1515794-f0005){#F4}

![Functional and Mechanistic Differences between Classical RNAi and Nuclear RNAi, and Different Phases of Nuclear RNAi in *C. elegans*\
(A) Classical RNAi provides an immediate silencing response at the same generation when animals are exposed to dsRNA. Classical RNAi silencing is at the post-transcriptional level, and is not transgenerationally heritable. In contrast, nuclear RNAi silencing takes more than one generation to be established. Nuclear RNAi represses target loci at the transcriptional level and is heritable. It provides long-term transgenerational silencing.\
(B) Establishment and maintenance phases of nuclear RNAi involve different transcriptional activities and genetic requirements.](nihms-1515794-f0006){#F5}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                                                                                                          SOURCE                         IDENTIFIER
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ -------------------------------------------------
  Antibodies                                                                                                                                                                                                                  
                                                                                                                                                                                                                              
  Anti-Histone H3 (tri methyl K9) antibody - ChIP Grade                                                                                                                                        Abcam                          Cat\# 8898, Lot\# GR285794-2;RRID: AB_306848
  Anti-RNA polymerase II CTD repeat YSPTSPS (phospho S2) antibody - ChIP Grade                                                                                                                 Abcam                          Cat\# ab5095, Lot\# GR231750-1; RRID: AB_304749
                                                                                                                                                                                                                              
  Bacterial and Virus Strains                                                                                                                                                                                                 
                                                                                                                                                                                                                              
  *E. coli* OP50                                                                                                                                                                               CGC                            NA
  *E. coli* HT115(DE3)                                                                                                                                                                         CGC                            NA
                                                                                                                                                                                                                              
  Chemicals, Peptides, and Recombinant Proteins                                                                                                                                                                               
                                                                                                                                                                                                                              
  FORMALDEHYDE 37% MICROFILTERED                                                                                                                                                               Electron Microscopy Sciences   Cat\# 15686
  TRIzol-REAGENT                                                                                                                                                                               Invitrogen                     Cat\# 15596-018
  RNA Fragmentation Reagents                                                                                                                                                                   Invitrogen                     Cat\# AM8740
  T4 PNK                                                                                                                                                                                       NEB                            Cat\# M0201L
  T4 RNA Ligase 1                                                                                                                                                                              NEB                            Cat\# M0204S
  T4 RNA ligase 2, truncated                                                                                                                                                                   NEB                            Cat\# M0242L
                                                                                                                                                                                                                              
  Critical Commercial Assays                                                                                                                                                                                                  
                                                                                                                                                                                                                              
  KAPA Hyper Prep Kit                                                                                                                                                                          KAPABIOSYSTEM                  Cat\# KK8505
  KAPA SYBR FAST Universal 2 × PCR Master Mix                                                                                                                                                  KAPABIOSYSTEM                  Cat\# KK4602
                                                                                                                                                                                                                              
  Deposited Data                                                                                                                                                                                                              
                                                                                                                                                                                                                              
  NGS data                                                                                                                                                                                     This study                     NGS: GSE117662
                                                                                                                                                                                                                              
  Experimental Models: Organisms/Strains                                                                                                                                                                                      
                                                                                                                                                                                                                              
  C. elegans Bristol strain                                                                                                                                                                    CGC                            N2
  set-32(ok1457) I                                                                                                                                                                             ([@R11])                       VC967
  set-32(red11) I                                                                                                                                                                              This study                     CSS186
  nrde-2(gg091) II                                                                                                                                                                             ([@R20])                       YY186
  met-2(n4256) III                                                                                                                                                                             ([@R3])                        MT13293
  hrde-1(tm1200) III                                                                                                                                                                           ([@R11])                       TM1300
  set-25(n5021) III                                                                                                                                                                            ([@R3])                        MT17463
  set-26(tm3526) IV                                                                                                                                                                            ([@R11])                       TM3526
  set-9(red8) IV                                                                                                                                                                               ([@R23])                       CSS164
  set-26(tm3526) set-9(red8)                                                                                                                                                                   this study                     CSS412
  set-32(red11); hrde-1(tm1200)                                                                                                                                                                this study                     CSS425
  met-2(n4256) set-25(n5021)                                                                                                                                                                   ([@R23])                       CSS95
  set-32(red11);met-2(n4256) set-25(n5021)                                                                                                                                                     ([@R23])                       CSS419
  met-2(n4256) set-25(n5021) hrde-1(tm1200)                                                                                                                                                    this study                     CSS400
  set-32(red11);met-2(n4256) set-25(n5021) hrde-1(tm1200)                                                                                                                                      this study                     CSS415
                                                                                                                                                                                                                              
  Oligonucleotides                                                                                                                                                                                                            
                                                                                                                                                                                                                              
  forward qPCR primer for oma-1 mRNA: ctacaggactctgcccatacg                                                                                                                                    IDT                            SG-1016
  reverse qPCR primer for oma-1 mRNA: ggcctggcaaacatttctaa                                                                                                                                     IDT                            SG-1019
  forward qPCR primer for oma-1 pre-mRNA:ttaatgacc tctgttttaggtg                                                                                                                               IDT                            SG-1022
  reverse qPCR primer for oma-1 pre-mRNA:gaacccaaaa ccatcgaatc                                                                                                                                 IDT                            SG-1023
  forward qPCR primer for oma-1 ChIP: acatgtatttttgctcactgtaa                                                                                                                                  IDT                            SG-1018
  reverse qPCR primer for oma-1 ChIP: ggcctggcaaacatttctaa                                                                                                                                     IDT                            SG-1019
  forward ChIP qPCR primer for an H3K9me3 negative control locus: agccatggcacaaaaagaag                                                                                                         IDT                            SG-1044
  reverse ChIP qPCR primer for an H3K9me3 negative control locus: tgtggcctgagaagacaaaa                                                                                                         IDT                            SG-1045
  forward qPCR primer for tba-1 mRNA: TCCAAGCGAG ACCAGGCTTCAG                                                                                                                                  IDT                            SG-1108
  reverse qPCR primer for tba-1 mRNA: TCAACACTGCCAT CGCCGCC                                                                                                                                    IDT                            SG-1109
  HR oligo for set-32 (red11) CRISPR allele): tcttcgaatatacagacacg aatgttttgaacccgGCTAGCAtgctccgcaagaaacattgcgaaagcatgta ttatgtctcaaaaggaagagaat                                               IDT                            SG-1173
  T7 *in vitro* transcription template oligo for crRNA targeting hrde-1 tm1200 mutation (seed sequence: taatcgtatgTggaaaccg): AAAACAGCATAGCTCTAAAAC cggtttccAcatacgatta CCCTATAGTGAGTCGTATTA   IDT                            SG-1285
  upstream PCR primer used to generated a 424 bp genomic DNA fragment as template DNA to repair the hrde-1 (tm1200) mutation by CRISPR: aaggagaagttgcccaggag                                   IDT                            SG-1292
  downstream PCR primer used to generated a 424 bp genomic DNA fragment as template DNA to repair the hrde-1(tm1200) mutation by CRISPR: atctcggtacctgtcgttgc                                  IDT                            SG-1293
                                                                                                                                                                                                                              
  Recombinant DNA                                                                                                                                                                                                             
                                                                                                                                                                                                                              
  oma-1 dsRNA feeding plasmid                                                                                                                                                                  ([@R23])                       pSG42
                                                                                                                                                                                                                              
  Software and Algorithms                                                                                                                                                                                                     
                                                                                                                                                                                                                              
  Bowtie 0.12.7                                                                                                                                                                                ([@R26])                       NA

###### Highlights

-   The onset of nuclear RNAi is a transgenerational process

-   A putative histone methyltransferase, SET-32, promotes silencing establishment

-   MET-2, SET-25, and SET-32 are involved for the maintenance of silencing

-   For endogenous targets, their requirements are conditional on *hrde-1* mutation
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